SANUWAVE’S Pace Technology Is a Novel, Safe and Cost-Effective Method to Treat Severe Burns
SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, announced that a European scientific study reporting the successful treatment of severe...
Researchers find low prevalence of tamoxifen use for prevention of breast cancer among women
Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without...
HIV/AIDS Therapy: Studies from D.Harte and colleagues reveal new findings on HIV/AIDS therapy
A new study, ' Immunosuppression among HIV-1-positive patients attending for care: experience from two large HIV centers in the UK ' is revealed by...
Cancer Therapy: New hope for therapy in heartburn-related cancer
Cancer of the gullet, or oesophagus, is one of the ten most common cancers in the Western world, and there have been recent alarming...
Johannes Gutenberg University forms a Joint Venture with Nagasaki University
The University Medical Center of Johannes Gutenberg University Mainz and Nagasaki University in Japan plan to cooperate more closely in the future. At the...
According to a study Sexual function does not continuously decline after radiation therapy treatment
According to a study in the January 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for...
The first robotic system has been named one of 2009’s top 10 scientific discoveries...
The scientists designed the robot, called Adam, to carry out each stage of the scientific process automatically without the need for further human intervention....
PET plays critical role in supporting Parkinson’s Disease Research
A study conducted to measure the effectiveness of dopamine cell transplantation in Parkinson’s disease patients shows significant improvements in motor skills and brain function,...
Hutchinson Center researcher secures $7.9 million NCI grant for esophageal cancer research
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year,...
Study indicates potential for dramatic reduction in TomoTherapy Treatment Time
TomoTherapy Incorporated announced that a research study published in the November 11, 2009 International Journal of Radiation Oncology * Biology * Physics—commonly known as...